{"id":2676,"date":"2021-02-16T01:58:12","date_gmt":"2021-02-16T01:58:12","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2676"},"modified":"2023-08-29T18:01:52","modified_gmt":"2023-08-29T18:01:52","slug":"invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2676","title":{"rendered":"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458"},"content":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=IXC&amp;lang=cn\">Invex Therapeutics (ASX: IXC)<\/a>\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002<\/p>\n<p>Baldwin\u535a\u58eb\u62e5\u6709\u8d85\u8fc720\u5e74\u7684\u5de5\u4f5c\u7ecf\u9a8c\u5728\u4e3a\u764c\u75c7\u6cbb\u7597\u836f\u7269\u5f00\u53d1\u9879\u76ee\u548c\u773c\u79d1\u7684\u8ff9\u8c61,\u5c24\u5176\u662f\u540e\u671f\u7684\u9996\u5e2d\u6267\u884c\u5b98\u548c\u8463\u4e8b\u603b\u7ecf\u7406\u751f\u7269\u5236\u836f<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=OPT&amp;lang=cn\">Opthea Limited (ASX:OPT)<\/a>,\u8fd9\u662f\u53d1\u5c55\u4e00\u79cd\u65b0\u578b\u7597\u6cd5\u6cbb\u7597\u89c6\u7f51\u819c\u75be\u75c5,\u5305\u62ec\u6e7f\u5e74\u9f84\u76f8\u5173\u6027\u9ec4\u6591\u53d8\u6027(\u6e7f\u6027AMD)\u3002<\/p>\n<p>Invex\u516c\u53f8\u4e13\u6ce8\u4e8e<a href=\"http:\/\/smallcaps-production.test\/invex-therapeutics-phase-three-trial-repurpose-drug-brain-disorder\/?lang=cn\">\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u5176\u836f\u7269Presendin&#x2122;<\/a>\uff0c\u7528\u4e8e\u6cbb\u7597\u4e0e\u9885\u5185\u538b\u5347\u9ad8\u76f8\u5173\u7684\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff0c\u5e76\u5c06Baldwin\u535a\u58eb\u89c6\u4e3a\u5176\u8463\u4e8b\u4f1a\u201c\u6b22\u8fce\u7684\u65b0\u6210\u5458\u201d\u3002<\/p>\n<p>\u201cBaldwin\u535a\u58eb\u7684\u5927\u91cf\u836f\u7269\u5f00\u53d1\u7684\u7ecf\u9a8c,\u7ba1\u7406\u53c2\u4e0e\u548c\u4e34\u5e8a\u8bd5\u9a8c\u8bbe\u8ba1\u548c\u6267\u884c\u5c06\u5b9d\u8d35\u7684Invex\u516c\u53f8\u8fdb\u5c55Presendin&#x2122;\u57282021\u5e74\u8fdb\u5165\u7b2c\u4e09\u9636\u6bb5\u7814\u7a76\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u8840\u538b(IIH),\u4e00\u4e2a\u75be\u75c5,\u591a\u8fbe\u56db\u5206\u4e4b\u4e00\u7684\u60a3\u8005\u51fa\u73b0\u6c38\u4e45\u6027\u89c6\u529b\u4e27\u5931,\u201cInvex\u4e3b\u5e2d\u6770\u68eeLoveridge\u535a\u58eb\u8bf4\u3002<\/p>\n<p>Invex\u8ba1\u5212\u4e8e2021\u5e74\u4e0a\u534a\u5e74\u8fdb\u884c\u4eba\u7c7b\u836f\u4ee3\u52a8\u529b\u5b66\u548c\u52a8\u7269\u8010\u53d7\u6027\u7814\u7a76\uff0c\u5e76\u8ba1\u5212\u4e8e\u4eca\u5e74\u4e0b\u534a\u5e74\u5728\u6b27\u6d32\u542f\u52a8III\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<h2>\u4e34\u5e8a\u5f00\u53d1\u7ecf\u9a8c<\/h2>\n<p>\u5728Baldwin\u535a\u58eb\u7684\u9886\u5bfc\u4e0b,Opthea\u8fc5\u901f\u5148\u8fdb\u773c\u79d1\u9879\u76ee\u901a\u8fc7\u4e00\u671f\u548c\u4e8c\u671f\u4e34\u5e8a\u5f00\u53d1,\u6dfb\u52a0\u5230S&amp;P \/ ASX 300 2020\u5e746\u6708\u548c2020\u5e7410\u6708,\u5b8c\u6210\u4e861.8\u4ebf\u6fb3\u5143\u7684\u9996\u6b21\u516c\u5f00\u53d1\u884c(ipo)\u548c\u5728\u7f8e\u56fd\u7eb3\u65af\u8fbe\u514b\u4ea4\u6613\u6240\u4e0a\u5e02\u4e24\u4e2a\u5173\u952e\u7684\u6e7f\u6027AMD\u7b2c\u4e09\u9636\u6bb5\u7814\u7a76\u8fdb\u5c55\u3002<\/p>\n<p>\u5728\u52a0\u5165Opthea\u4e4b\u524d\uff0cBaldwin\u535a\u58eb\u662fGenentech(\u73b0\u5728\u662fRoche)\u7684\u535a\u58eb\u540e\u7814\u7a76\u5458\uff0c\u4e4b\u540e\u8fdb\u5165\u4e86Genentech\u7684\u5546\u4e1a\u90e8\u95e8\u3002<\/p>\n<p>Baldwin\u535a\u58eb\u62e5\u6709\u58a8\u5c14\u672c\u5927\u5b66\u533b\u5b66\u535a\u58eb\u5b66\u4f4d\uff0c\u66fe\u5728\u8def\u5fb7\u7ef4\u5e0c\u764c\u75c7\u7814\u7a76\u6240\u8fdb\u884c\u535a\u58eb\u7814\u7a76\uff0c\u5e76\u662f\u6fb3\u5927\u5229\u4e9a\u516c\u53f8\u8463\u4e8b\u7814\u7a76\u6240\u7684\u6210\u5458\u3002\u5979\u8fd8\u62c5\u4efbAusbiotech\u7684\u8463\u4e8b\u4f1a\u526f\u4e3b\u5e2d\u3002<\/p>\n<h2>\u8463\u4e8b\u4f1a\u85aa\u916c<\/h2>\n<p>\u6839\u636eInvex\u7684\u58f0\u660e\uff0cBaldwin\u535a\u58eb\u4f5c\u4e3a\u975e\u6267\u884c\u8463\u4e8b\u6bcf\u5e74\u5c06\u83b7\u5f975\u4e07\u7f8e\u5143\u7684\u5956\u91d1\u3002<\/p>\n<p>\u5728\u516c\u53f8\u4e0b\u6b21\u80a1\u4e1c\u5927\u4f1a\u4e0a\u83b7\u5f97\u80a1\u4e1c\u6279\u51c6\u540e\uff0cInvex\u8fd8\u5c06\u5411\u9c8d\u5fb7\u6e29\u535a\u58eb\u53d1\u884c40\u4e07\u80a1\u671f\u6743\uff0c\u4ee5\u6536\u8d2d\u8be5\u516c\u53f8\u7684\u80a1\u7968\u3002\u6bcf\u4e00\u4efd\u671f\u6743\u7684\u6267\u884c\u4ef7\u4e3a1.10\u7f8e\u5143\uff0c\u8ba1\u7b97\u65b9\u6cd5\u662f\u5bf9\u622a\u81f32\u670812\u65e5(\u5305\u62ec2\u670812\u65e5)Invex\u80a1\u79685\u5929\u6210\u4ea4\u91cf\u52a0\u6743\u5747\u4ef70.8345\u6fb3\u5143\u7684\u6ea2\u4ef731.8%\u3002<\/p>\n<p>\u8fd9\u4e9b\u671f\u6743\u5c06\u67093\u5e74\u7684\u671f\u9650\uff0c\u5305\u62ec12\u4e2a\u6708\u548c24\u4e2a\u6708\u7684\u6301\u7eed\u670d\u52a1\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002 Baldwin\u535a\u58eb\u62e5\u6709\u8d85\u8fc720\u5e74\u7684\u5de5\u4f5c\u7ecf\u9a8c\u5728\u4e3a\u764c\u75c7\u6cbb\u7597\u836f\u7269\u5f00\u53d1\u9879\u76ee\u548c\u773c\u79d1\u7684\u8ff9\u8c61,\u5c24\u5176\u662f\u540e\u671f\u7684\u9996\u5e2d\u6267\u884c\u5b98\u548c\u8463\u4e8b\u603b\u7ecf\u7406\u751f\u7269\u5236\u836fOpthea Limited (ASX:OPT),\u8fd9\u662f\u53d1\u5c55\u4e00\u79cd\u65b0\u578b\u7597\u6cd5\u6cbb\u7597\u89c6\u7f51\u819c\u75be\u75c5,\u5305\u62ec\u6e7f\u5e74\u9f84\u76f8\u5173\u6027\u9ec4\u6591\u53d8\u6027(\u6e7f\u6027AMD)\u3002 Invex\u516c\u53f8\u4e13\u6ce8\u4e8e\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u5176\u836f\u7269Presendin&#x2122;\uff0c\u7528\u4e8e\u6cbb\u7597\u4e0e\u9885\u5185\u538b\u5347\u9ad8\u76f8\u5173\u7684\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\uff0c\u5e76\u5c06Baldwin\u535a\u58eb\u89c6\u4e3a\u5176\u8463\u4e8b\u4f1a\u201c\u6b22\u8fce\u7684\u65b0\u6210\u5458\u201d\u3002 \u201cBaldwin\u535a\u58eb\u7684\u5927\u91cf\u836f\u7269\u5f00\u53d1\u7684\u7ecf\u9a8c,\u7ba1\u7406\u53c2\u4e0e\u548c\u4e34\u5e8a\u8bd5\u9a8c\u8bbe\u8ba1\u548c\u6267\u884c\u5c06\u5b9d\u8d35\u7684Invex\u516c\u53f8\u8fdb\u5c55Presendin&#x2122;\u57282021\u5e74\u8fdb\u5165\u7b2c\u4e09\u9636\u6bb5\u7814\u7a76\u6cbb\u7597\u7279\u53d1\u6027\u9885\u5185\u9ad8\u8840\u538b(IIH),\u4e00\u4e2a\u75be\u75c5,\u591a\u8fbe\u56db\u5206\u4e4b\u4e00\u7684\u60a3\u8005\u51fa\u73b0\u6c38\u4e45\u6027\u89c6\u529b\u4e27\u5931,\u201cInvex\u4e3b\u5e2d\u6770\u68eeLoveridge\u535a\u58eb\u8bf4\u3002 Invex\u8ba1\u5212\u4e8e2021\u5e74\u4e0a\u534a\u5e74\u8fdb\u884c\u4eba\u7c7b\u836f\u4ee3\u52a8\u529b\u5b66\u548c\u52a8\u7269\u8010\u53d7\u6027\u7814\u7a76\uff0c\u5e76\u8ba1\u5212\u4e8e\u4eca\u5e74\u4e0b\u534a\u5e74\u5728\u6b27\u6d32\u542f\u52a8III\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u4e34\u5e8a\u5f00\u53d1\u7ecf\u9a8c \u5728Baldwin\u535a\u58eb\u7684\u9886\u5bfc\u4e0b,Opthea\u8fc5\u901f\u5148\u8fdb\u773c\u79d1\u9879\u76ee\u901a\u8fc7\u4e00\u671f\u548c\u4e8c\u671f\u4e34\u5e8a\u5f00\u53d1,\u6dfb\u52a0\u5230S&amp;P \/ ASX 300 2020\u5e746\u6708\u548c2020\u5e7410\u6708,\u5b8c\u6210\u4e861.8\u4ebf\u6fb3\u5143\u7684\u9996\u6b21\u516c\u5f00\u53d1\u884c(ipo)\u548c\u5728\u7f8e\u56fd\u7eb3\u65af\u8fbe\u514b\u4ea4\u6613\u6240\u4e0a\u5e02\u4e24\u4e2a\u5173\u952e\u7684\u6e7f\u6027AMD\u7b2c\u4e09\u9636\u6bb5\u7814\u7a76\u8fdb\u5c55\u3002 \u5728\u52a0\u5165Opthea\u4e4b\u524d\uff0cBaldwin\u535a\u58eb\u662fGenentech(\u73b0\u5728\u662fRoche)\u7684\u535a\u58eb\u540e\u7814\u7a76\u5458\uff0c\u4e4b\u540e\u8fdb\u5165\u4e86Genentech\u7684\u5546\u4e1a\u90e8\u95e8\u3002 Baldwin\u535a\u58eb\u62e5\u6709\u58a8\u5c14\u672c\u5927\u5b66\u533b\u5b66\u535a\u58eb\u5b66\u4f4d\uff0c\u66fe\u5728\u8def\u5fb7\u7ef4\u5e0c\u764c\u75c7\u7814\u7a76\u6240\u8fdb\u884c\u535a\u58eb\u7814\u7a76\uff0c\u5e76\u662f\u6fb3\u5927\u5229\u4e9a\u516c\u53f8\u8463\u4e8b\u7814\u7a76\u6240\u7684\u6210\u5458\u3002\u5979\u8fd8\u62c5\u4efbAusbiotech\u7684\u8463\u4e8b\u4f1a\u526f\u4e3b\u5e2d\u3002 \u8463\u4e8b\u4f1a\u85aa\u916c \u6839\u636eInvex\u7684\u58f0\u660e\uff0cBaldwin\u535a\u58eb\u4f5c\u4e3a\u975e\u6267\u884c\u8463\u4e8b\u6bcf\u5e74\u5c06\u83b7\u5f975\u4e07\u7f8e\u5143\u7684\u5956\u91d1\u3002 \u5728\u516c\u53f8\u4e0b\u6b21\u80a1\u4e1c\u5927\u4f1a\u4e0a\u83b7\u5f97\u80a1\u4e1c\u6279\u51c6\u540e\uff0cInvex\u8fd8\u5c06\u5411\u9c8d\u5fb7\u6e29\u535a\u58eb\u53d1\u884c40\u4e07\u80a1\u671f\u6743\uff0c\u4ee5\u6536\u8d2d\u8be5\u516c\u53f8\u7684\u80a1\u7968\u3002\u6bcf\u4e00\u4efd\u671f\u6743\u7684\u6267\u884c\u4ef7\u4e3a1.10\u7f8e\u5143\uff0c\u8ba1\u7b97\u65b9\u6cd5\u662f\u5bf9\u622a\u81f32\u670812\u65e5(\u5305\u62ec2\u670812\u65e5)Invex\u80a1\u79685\u5929\u6210\u4ea4\u91cf\u52a0\u6743\u5747\u4ef70.8345\u6fb3\u5143\u7684\u6ea2\u4ef731.8%\u3002 \u8fd9\u4e9b\u671f\u6743\u5c06\u67093\u5e74\u7684\u671f\u9650\uff0c\u5305\u62ec12\u4e2a\u6708\u548c24\u4e2a\u6708\u7684\u6301\u7eed\u670d\u52a1\u3002<\/p>\n","protected":false},"author":5,"featured_media":10845,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[273],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458<\/title>\n<meta name=\"description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458\" \/>\n<meta property=\"og:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-16T01:58:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Invex-Therapeutics-ASX-IXC-biotech-Dr-Megan-Baldwin.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458\" \/>\n<meta name=\"twitter:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Invex-Therapeutics-ASX-IXC-biotech-Dr-Megan-Baldwin.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/\",\"name\":\"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-02-16T01:58:12+00:00\",\"dateModified\":\"2023-08-29T18:01:52+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458","description":"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458","og_description":"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/","og_site_name":"smallcapsCN","article_published_time":"2021-02-16T01:58:12+00:00","article_modified_time":"2023-08-29T18:01:52+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Invex-Therapeutics-ASX-IXC-biotech-Dr-Megan-Baldwin.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458","twitter_description":"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/02\/Invex-Therapeutics-ASX-IXC-biotech-Dr-Megan-Baldwin.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/","url":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/","name":"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-02-16T01:58:12+00:00","dateModified":"2023-08-29T18:01:52+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u5236\u836f\u516c\u53f8Invex Therapeutics (ASX: IXC)\u6b22\u8fce\u7ecf\u9a8c\u4e30\u5bcc\u7684\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u52a0\u5165\u8463\u4e8b\u4f1a\uff0c\u62c5\u4efb\u72ec\u7acb\u975e\u6267\u884c\u8463\u4e8b\uff0c\u5373\u65e5\u8d77\u751f\u6548\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/invex-therapeutics-appoints-biotech-expert-dr-megan-baldwin-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Invex Therapeutics\u4efb\u547d\u751f\u7269\u6280\u672f\u4e13\u5bb6Megan Baldwin\u535a\u58eb\u4e3a\u8463\u4e8b\u4f1a\u6210\u5458"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2676"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2676"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2676\/revisions"}],"predecessor-version":[{"id":10844,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2676\/revisions\/10844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10845"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}